Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
121 Results for "
hepatocyte growth factor
" in MedChemExpress (MCE) Product Catalog:
Products (121)
121 Results for "hepatocyte growth factor" in MCE Product Catalog:
6
6 Cited Publications
Cat. No.: HY-16969
CAS No.: 1401708-83-5
Synonyms: PNB-0408; N-hexanoic-Try-Ile-(6)-amino hexanoic amide; Hexanoyl-Tyr-Ile-Ahx-NH2
Target:
Research Areas:
Dihexa, an oligopeptide drug, is an orally active and blood-brain barrier-permeable angiotensin IV analog. Dihexa binds to hepatocyte growth factor (HGF) with high affinity (Kd=65 pM) and potentiates its activity at its receptor, c-Met. Dihexa exhibits excellent antidementia activity and improves cognitive function in animal models. Dihexa may have therapeutic potential as a treatment Alzheimer’s disease .
6
6 Cited Publications
Cat. No.: HY-P7121
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HGF; hepatocyte growth factor (Hepapoietin A; Scatter factor); Prev. DFNB39; Lung Fibroblast-Derived Mitogen; HPTA; Hepatopoietin-A; SF; Scatter factor; F-TCF; Deafness, Autosomal Recessive 39; HGFB; Hepatopoietin A; hepatocyte growth factor; Fibroblast-D
Species:
Human
Source:
CHO
2
2 Cited Publications
Target:
Research Areas:
SRI 31215 (TFA) is a Matriptase/Hepsin/hepatocyte growth factor activator (HGFA) triplex inhibitor and mimics the activity of HAI-1/2 (endogenous inhibitors of HGF activation). SRI 31215 has potent inhibitory activity against matriptase, hepsin and HGFA with IC50 values of 0.69 μM, 0.65 μM and 0.30 μM, respectively. SRI 31215 can be used for the research of cancer .
2
2 Cited Publications
Cat. No.: HY-P70627
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HGF; hepatocyte growth factor (Hepapoietin A; Scatter factor); Prev. DFNB39; Lung Fibroblast-Derived Mitogen; HPTA; Hepatopoietin-A; SF; Scatter factor; F-TCF; Deafness, Autosomal Recessive 39; HGFB; Hepatopoietin A; hepatocyte growth factor; Fibroblast-Derived Tumor Cytotoxic factor
Species:
Human
Source:
HEK293
2
2 Cited Publications
Cat. No.: HY-P70832
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HABP2; factor VII Activating Protein; Hyaluronan Binding Protein 2; Hyaluronan-Binding Protein 2; HGFAL; FVII Activator; PHBP; PHBSP; FSAP; Hyaluronic Acid Binding Protein 2; HABP; Plasma Hyaluronan-Binding Protein; hepatocyte growth factor Activator-Like
Species:
Human
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P1415A
Target:
Research Areas:
Cardiovascular Disease Neurological Disease Metabolic Disease
1
1 Cited Publications
Cat. No.: HY-P701103
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: MST1; NF15S2; Prev. D3F15S2; Macrophage Stimulatory Protein; Prev. DNF15S2; Macrophage Stimulating 1 (hepatocyte growth factor-Like); Prev. HGFL; hepatocyte growth factor-Like Protein Homolog; MSP; hepatocyte growth factor-Like; hepatocyte growth factor-L
Species:
Mouse
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P73101
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: HGF; hepatocyte growth factor (Hepapoietin A; Scatter factor); Prev. DFNB39; Lung Fibroblast-Derived Mitogen; HPTA; Hepatopoietin-A; SF; Scatter factor; F-TCF; Deafness, Autosomal Recessive 39; HGFB; Hepatopoietin A; hepatocyte growth factor; Fibroblast-D
Species:
Rat
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P73928
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: HGF; hepatocyte growth factor (Hepapoietin A; Scatter factor); Prev. DFNB39; Lung Fibroblast-Derived Mitogen; HPTA; Hepatopoietin-A; SF; Scatter factor; F-TCF; Deafness, Autosomal Recessive 39; HGFB; Hepatopoietin A; hepatocyte growth factor; Fibroblast-D
Species:
Mouse
Source:
HEK293
1
1 Cited Publications
Cat. No.: HY-P72267
Purity: ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: MET; Soluble MET Variant 13; MET Proto-Oncogene, Receptor Tyrosine Kinase; Soluble MET Variant 14; hepatocyte growth factor Receptor; Soluble MET Variant 15; DFNB97; Soluble MET Variant 1; RCCP2; Soluble MET Variant 2; HGFR; Soluble MET Variant 3; Tyrosin
Species:
Human
Source:
HEK293
Cat. No.: HY-P99391
CAS No.: 1781223-80-0
Synonyms: ABT-700; ABBV-400 Antibody
Target:
Research Areas:
Synonyms: TAS-115
Target:
Research Areas:
Pamufetinib (TAS-115) is a potent VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.
Synonyms: ANG-3777
Target:
Research Areas:
Terevalefim (ANG-3777), an hepatocyte growth factor (HGF) mimetic, selectively activates the c-Met receptor .
Cat. No.: HY-P99217
CAS No.: 872514-65-3
Synonyms: AMG 102
Target:
Research Areas:
Synonyms: ONO-AP 500-02
Target:
Research Areas:
ONO 1301 (ONO-AP 500-02), a prostaglandin (PG) I2 mimetic, is an orally active, long-acting prostacyclin agonist with thromboxane-synthase inhibitory activity. ONO 1301 promotes production of hepatocyte growth factor (HGF) from various cell types and ameliorates ischemia-induced left ventricle dysfunction in the mouse, rat and pig .
Cat. No.: HY-P99196
CAS No.: 1174900-84-5
Target:
Research Areas:
Cat. No.: HY-106961A
CAS No.: 153814-74-5
Synonyms: (Z)-ONO-AP 500-02
Target:
Research Areas:
(Z)-ONO 1301 is the isomer of ONO 1301 (HY-106961), and can be used as an experimental control. ONO 1301 (ONO-AP 500-02), a prostaglandin (PG) I2 mimetic, is an orally active, long-acting prostacyclin agonist with thromboxane-synthase inhibitory activity. ONO 1301 promotes production of hepatocyte growth factor (HGF) from various cell types and ameliorates ischemia-induced left ventricle dysfunction in the mouse, rat and pig .
Synonyms: ATH-1017
Target:
Research Areas:
Fosgonimeton (ATH-1017) is a hepatocyte growth factor receptor (c-Met/HGFR) agonist. Fosgonimeton has neuroprotective effects in both LPS (HY-D1056) -induced neuroinflammation and Aβ-induced AD models .
Synonyms: TAS-115 mesylate
Target:
Research Areas:
Pamufetinib (TAS-115) mesylate is a potent VEGFRand hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor, with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.
Cat. No.: HY-P2185A
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
